Manje, ngokokuqala ngqá emhlabeni jikelele, i-VAD (i-FiVAD) ehlangene, efakelwayo ngokuphelele isisetshenziswe ngempumelelo ngokuhlanganisa i-Calon Cardio MiniVAD™ nohlelo lokushaja lwamandla angenantambo oluguquguqukayo olungenantambo lwe-Leviticus Cardio. Ukuphothulwa kocwaningo lwezinsuku ezingama-60 lwe-in-vivo lwangaphambi komtholampilo lwale FiVAD kuqinisekise ngempumelelo ukuhlanganiswa kwalobu buchwepheshe obubili obusha.
Lobu buchwepheshe obusha obuphazamisayo, i-FiVAD, buzovumela isiguli usuku olugcwele ngaphandle kwentambo noma uxhumano kunoma iyiphi into yangaphandle. Inqubo yokushajwa ngokwayo idinga kuphela ibhande elincane elizungeze isifuba sesiguli ebusuku. Ukuqedwa ngempumelelo kwekhebula lamandla kagesi kuyisinyathelo esikhulu esiya phambili esiholela eqophelweni eliphezulu lempilo lalezi ziguli ezigula kakhulu. Kuzoqinisekisa odokotela emhlabeni wonke ukuthi ukwelashwa kwe-VAD sekufinyelele ezingeni lokusetshenziswa okujwayelekile futhi kuzoholela ekusetshenzisweni okubanzi kwalokhu kwelashwa okusindisa impilo.
Icala lenziwa esikhungweni semfundo ephakeme esihlonishwa umhlaba wonke eCatholic University of Leuven, eBelgium. Impumelelo yalolu cwaningo oluyisiqalo iphawula esinye isinyathelo ekuhlanganisweni kwezinkampani ezimbili ezizibophezele ekuthatheni lolu shintsho olushintsha impilo ngokubambisana neziguli emhlabeni jikelele.
U-Stuart McConchie, oyi-CEO ye-Calon Cardio-Technology Ltd: “Inhlanganisela ye-MiniVAD yethu, eklanyelwe ukuthuthukisa ukuphatha igazi, kanye nobuchwepheshe obungenawaya be-Leviticus buhlinzeka ngohlelo lwe-VAD oluphephile nolusebenzisekayo ngempela, olumelela inqubekelaphambili enkulu kubuchwepheshe bephampu yegazi. Ngokuhlangene le FiVAD izothuthukisa kakhulu izimpilo zenani elikhulu leziguli ezihluleka kwenhliziyo sekwephuzile. ”
UMichael Zilbershlag, oyi-CEO yakwaLeviticus Cardio Ltd: “Ucwaningo lwethu lubonise ukuthi inhlanganisela yeCalon MiniVAD™ esebenza kahle kakhulu kanye neLeviticus FiVAD inikeza okokuqala ngqa iphampu yenhliziyo esebenza ngokugcwele ngaphandle kwesidingo sokushajwa kabusha amahora angaphezu kwe-10 okuvumela. ukukhululeka kunoma iyiphi impahla yangaphandle usuku lonke lokusebenza.”
UMarc Clement, uSihlalo weCalon Cardio-Technology Ltd: “Nginesiqiniseko sokuthi ngikhulumela zombili izinkampani uma ngisho ukuthi sijabule kangakanani ngomphumela wokuhlanganiswa kobuchwepheshe bethu obusafufusa. Sizibophezele ebudlelwaneni besikhathi eside obuzothuthukisa izinga lempilo yezinkulungwane zeziguli emhlabeni jikelele.”
"Impumelelo eyimpumelelo yezinsuku ezingama-60 yenkundla ye-MiniVAD ne-FiVAD iveza impumelelo ekhuthazayo ekuhlanganisweni okwengeziwe kwalezi zindlela ezimbili zobuchwepheshe obusha," kusho uSolwazi u-Ivan Netuka, udokotela ohlinzayo wenhliziyo, uSihlalo ku-Institute for Clinical and Experimental Medicine (IKEM), EPrague, Czech Republic.
USolwazi Stephen Westaby, udokotela ohlinza inhliziyo owaziwayo (manje osethathe umhlalaphansi) nomsunguli weCalon Cardio ugcizelela ukuthi “Ukubaluleka okubalulekile kokuhlanganiswa kobuchwepheshe beCalon Cardio kanye noLeviticus Cardio wukuqedwa kokutheleleka nge-driveline. Ukutheleleka kubulala izinga lempilo, kuthuthukisa i-thrombosis kanye ne-stroke, futhi ngokuvamile kuholela ekufeni okukhulu ngaphambi kwesikhathi. I-FiVAD edidiyelwe iwuhlelo olunamandla okudlula ukufakelwa kwenhliziyo njengokungenelela okuthandwayo ekuhlulekeni kwenhliziyo okuthuthukile, ngaphandle kokudinga ukuthi kufe omunye umuntu kuqala.”
“Uhlelo olufana nalolu luzonikeza iziguli inkululeko yokwenza ezikuthandayo isikhathi esingaphezu kosuku lonke lokusebenza ngaphandle kokuxhunywa ngamakhebula angaphandle. Lapho sisemtholampilo, lokhu kungaphezu kwalokho thina njengodokotela esasingase sikuphuphe ngekhwalithi yokuphila yesiguli se-VAD,” kunezela uProfesa Stephan Schueler, Inhloko yoMnyango Wokuhlinza Inhliziyo e-Newcastle Upon Tyne Hospitals NHS Foundation Trust, e-United Kingdom.
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- “Our study has demonstrated that the combination of the very effective Calon MiniVAD™ and the Leviticus FiVAD offers for the first time a fully functioning heart pump without the need to be recharged for more than 10 hours allowing freedom from any external equipment for a whole working day.
- The success of this ground-breaking study marks a further step in the integration of the two companies who are committed to taking this life changing innovation in partnership to patients across the globe.
- Professor Stephen Westaby, renowned heart surgeon (now retired) and a founder of Calon Cardio impresses that “The critical importance of the integration of the Calon Cardio and Leviticus Cardio technologies is the elimination of driveline infection.
